Baseline characteristics
glifo-combo
At the start of the extension study, the original 101 participants remained in the basal-bolus group, 90 participants were in the FRC group and 93 in the gliflo-combo group. At 24 months, there were additional 32 dropouts in the FRC group and 39 in the glifo-combo group (Fig. The trial has been completed in 24 months. BBI basal-bolus insulin, FRC fixed-ratio combination (basal insulin + GLP-1RAs), GC gliflo-combo (basal insulin + gliflozin)